WHO ICTRP trial
The Impact of Ultrasound-guided Stellate Ganglion Block on Patients with…
ChiCTR2500105936 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500105936 |
|---|---|
| Public title | The Impact of Ultrasound-guided Stellate Ganglion Block on Patients with Migraine Complicated by Sleep Disorders |
| Scientific title | The Impact of Ultrasound-guided Stellate Ganglion Block on Patients with Migraine Complicated by Sleep Disorders |
| Primary sponsor | The Affiliated Hospital of Qingdao University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Migraine Complicated by Sleep Disorders |
| Interventions | Experimental group:Under ultrasound guidance, patients received stellate ganglion block (SGB) with 5 - 10 ml of 1% lidocaine once daily. The first course of treatment, consisting of 10 interventions, was performed on the same side as the… |
| Registration date | Jul 15, 2025 |
| Target size | Experimental group:70;Control group:69 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: